LAUSR

As director of the National Heart, Lung, and Blood Institute (NHLBI), it is my privilege to be a public servant and an accountable steward of the nation’s investment in heart, lung, blood, and sleep research. The NHLBI strives to advance science that enhances human health through several enduring principles that have sustained the Institute’s legacy of excellence: value investigator-initiated fundamental discovery science; maintain a balanced portfolio across basic, translational, clinical, population, and implementation science; train a diverse new generation of scientists; support implementation science that empowers patients and partners to improve the nation’s health; and innovate an evidence-based elimination of health inequities. The pursuit of the NHLBI mission involves the collective effort of a diverse community of partners including patients, researchers, policymakers, care providers, professional organizations, and the private sector. Over the past 2 years, we engaged our partners in a process of unprecedented scope to create the NHLBI Strategic Vision , a framework of research priorities to guide the activities and initiatives that NHLBI will catalyze over the next decade.1 The Strategic Visioning process revealed an NHLBI community poised to take bold steps forward toward the prevention and preemption of cardiovascular disease. The Strategic Vision charts a future that exploits emerging disciplines and new tools and technologies in computation, imaging, and high-throughput omic analytics to further our understanding of normal biology, pathobiology, individual and population differences, precision medicine, data science, novel therapeutics and diagnostics, and workforce development. Below, I highlight 2 areas in the Strategic Vision that hold great promise for cardiovascular research and …